ALC

Alcon Inc
$74.12+$2.29+3.18%Price as of Nov 13, 2026, 7:31 PM ET

Key stats

Market cap
35.8B
Open
—
Day range
—
52-week range
$61.84 – $87.64
Volume
2.58M
Avg volume
2.27M

Earnings

Q4 FY25
Q4 FY24
Q4 FY23
Q4 FY22

Next earnings call Feb 26, 2027

About

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.

Employees
25,942